Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2011-07-29 Director's Dealing
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Director's Dealing 2011
Director's Dealing
2011-07-29 Danish
Director's Dealing 2011
Director's Dealing
2011-07-29 English
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' for an amount up to DKK 400 million. This action directly corresponds to the definition of a company buying back its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The document length is very short (407 chars), but it is a direct announcement of the transaction program itself, not merely an announcement that a report is attached, making POS more specific than RPA or RNS.
2011-07-22 English
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a previously initiated share buyback program, referencing the European Commission's Safe Harbour Regulation. It provides a table showing the number of shares purchased and the transaction value over several days (July 15 to July 21, 2011). This content directly relates to the company repurchasing or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document length is short (2757 chars), but it is a detailed report of transactions, not merely an announcement that a report is available, thus ruling out RPA/RNS.
2011-07-22 English
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes initiated a 'share buyback program' for an amount up to DKK 400 million. This action directly corresponds to the definition of a company buying back its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The document length is very short (407 chars), but it is a direct announcement of the transaction program itself, not merely an announcement that a report is attached, making POS more specific than RPA or RNS.
2011-07-15 English
Transaction in Own Shares 2011
Transaction in Own Shares Classification · 100% confidence The document text, written in Danish, explicitly discusses Novozymes initiating a share buyback program ('aktietilbagekøbsprogram') under a specific EU regulation (No. 2273/2003, 'Safe Harbour'). It specifies the total amount (400 million DKK) and the period (Feb 11, 2011, to Dec 31, 2011). This action directly relates to the company transacting in its own shares. The classification code corresponding to 'Report of the company buying back or selling its own shares (share repurchase/issuance)' is POS (Transaction in Own Shares). The document is short and appears to be an announcement of this activity.
2011-07-15 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.